SHISEIDO FUTURE SOLUTION LX INFINITE TREATMENT PRIMER- titanium dioxide, octinoxate, and ensulizole emulsion 
SHISEIDO AMERICAS CORPORATION

Disclaimer: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

----------

SHISEIDO FUTURE SOLUTION LX INFINITE TREATMENT PRIMER

Drug Facts

Active ingredientsPurpose
ENSULIZOLE 1.0%Sunscreen
OCTINOXATE 3.9%Sunscreen
TITANIUM DIOXIDE 4.1%Sunscreen

Uses

Warnings

For external use only

Do not use on damaged or broken skin

When using this product keep out of eyes. Rinse with water to remove.

Stop use and ask a doctor if rash occurs.

Keep out of reach of children. If product is swallowed, get medical help or contact a Poison Control Center right away.

Directions

For sunscreen use:

Inactive Ingredients

WATER∙DIMETHICONE∙BUTYLENE GLYCOL∙GLYCERIN∙ISOHEXADECANE∙SD ALCOHOL 40-B∙ZEA MAYS (CORN) STARCH∙PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE∙DIPHENYLSILOXY PHENYL TRIMETHICONE∙SILICA∙TRIISOSTEARIN∙DISTEARDIMONIUM HECTORITE∙CETYLETHYLHEXANOATE∙XYLITOL∙ERYTHRITOL∙TRIMETHYLSILOXYSILICATE∙TREHALOSE∙TOCOPHERYL ACETATE∙2-O-ETHYL ASCORBIC ACID∙PRUNUS SPECIOSA LEAF EXTRACT∙ANGELICA ACUTILOBA ROOT EXTRACT∙SCUTELLARIA BAICALENSIS ROOT EXTRACT∙CAMELLIA SINENSIS LEAF EXTRACT∙SODIUM ACETYLATED HYALURONATE∙ISODONIS JAPONICUS LEAF/STALK EXTRACT∙HYDROLYZED CONCHIOLIN PROTEIN∙ROSA ROXBURGHII FRUIT EXTRACT∙GOLD∙TRIETHANOLAMINE∙ISOSTEARIC ACID∙ALUMINUM HYDROXIDE∙STEARIC ACID∙DISODIUM EDTA∙ALCOHOL∙CALCIUM ALUMINUM BOROSILICATE∙BHT∙HYDROGEN DIMETHICONE∙TOCOPHEROL∙POLYSILICONE-2∙TRIETHOXYCAPRYLYLSILANE∙SODIUM CITRATE∙TIN OXIDE∙BARIUM SULFATE∙CITRIC ACID∙PHENOXYETHANOL∙FRAGRANCE∙TITANIUM DIOXIDE∙MICA∙IRON OXIDES

Other information

Protect this product in this container from excessive heat and direct sun.

Questions or comments?

Call toll free 1-800-906-7503

PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton

SHISEIDO
GINZA TOKYO

FUTURE SOLUTION LX
Infinite Treatment Primer

SkingenecellEnmei

BROAD SPECTRUM
SPF 30
SUNSCREEN

40mL NET WT. 1.4 OZ.

PRINCIPAL DISPLAY PANEL - 40 mL Tube Carton
SHISEIDO FUTURE SOLUTION LX INFINITE TREATMENT PRIMER 
titanium dioxide, octinoxate, and ensulizole emulsion
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:58411-657
Route of AdministrationTOPICAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
TITANIUM DIOXIDE (UNII: 15FIX9V2JP) (TITANIUM DIOXIDE - UNII:15FIX9V2JP) TITANIUM DIOXIDE1.77 g  in 40 mL
OCTINOXATE (UNII: 4Y5P7MUD51) (OCTINOXATE - UNII:4Y5P7MUD51) OCTINOXATE1.71 g  in 40 mL
ENSULIZOLE (UNII: 9YQ9DI1W42) (ENSULIZOLE - UNII:9YQ9DI1W42) ENSULIZOLE0.428 g  in 40 mL
Inactive Ingredients
Ingredient NameStrength
WATER (UNII: 059QF0KO0R)  
DIMETHICONE (UNII: 92RU3N3Y1O)  
BUTYLENE GLYCOL (UNII: 3XUS85K0RA)  
GLYCERIN (UNII: PDC6A3C0OX)  
ISOHEXADECANE (UNII: 918X1OUF1E)  
PEG-9 POLYDIMETHYLSILOXYETHYL DIMETHICONE (UNII: TYP81E471F)  
DIPHENYLSILOXY PHENYL TRIMETHICONE (UNII: I445L28B12)  
STARCH, CORN (UNII: O8232NY3SJ)  
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
TRIISOSTEARIN (UNII: 71503RH8KG)  
DISTEARDIMONIUM HECTORITE (UNII: X687XDK09L)  
XYLITOL (UNII: VCQ006KQ1E)  
CETYL ETHYLHEXANOATE (UNII: 134647WMX4)  
TROLAMINE (UNII: 9O3K93S3TK)  
TRIMETHYLSILOXYSILICATE (M/Q 0.6-0.8) (UNII: 5041RX63GN)  
ERYTHRITOL (UNII: RA96B954X6)  
MICA (UNII: V8A1AW0880)  
ISOSTEARIC ACID (UNII: X33R8U0062)  
PHENOXYETHANOL (UNII: HIE492ZZ3T)  
TREHALOSE (UNII: B8WCK70T7I)  
ALUMINUM HYDROXIDE (UNII: 5QB0T2IUN0)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
EDETATE DISODIUM (UNII: 7FLD91C86K)  
FERRIC OXIDE RED (UNII: 1K09F3G675)  
FERRIC OXIDE YELLOW (UNII: EX438O2MRT)  
FERROSOFERRIC OXIDE (UNII: XM0M87F357)  
ALCOHOL (UNII: 3K9958V90M)  
.ALPHA.-TOCOPHEROL ACETATE, DL- (UNII: WR1WPI7EW8)  
CALCIUM ALUMINUM BOROSILICATE (UNII: 3JRB8A35M0)  
BUTYLATED HYDROXYTOLUENE (UNII: 1P9D0Z171K)  
2-O-ETHYL ASCORBIC ACID (UNII: 801M14RK9K)  
HYDROGEN DIMETHICONE (13 CST) (UNII: 4QGR4P2YOI)  
.ALPHA.-TOCOPHEROL (UNII: H4N855PNZ1)  
TRIETHOXYCAPRYLYLSILANE (UNII: LDC331P08E)  
SODIUM CITRATE, UNSPECIFIED FORM (UNII: 1Q73Q2JULR)  
STANNIC OXIDE (UNII: KM7N50LOS6)  
PRUNUS SPECIOSA LEAF (UNII: Q71D900FVU)  
ANGELICA ACUTILOBA ROOT (UNII: 3W51R3EK30)  
SCUTELLARIA BAICALENSIS ROOT (UNII: 7J95K7ID2S)  
GREEN TEA LEAF (UNII: W2ZU1RY8B0)  
SODIUM ACETYLATED HYALURONATE (UNII: WN66R7GL93)  
BARIUM SULFATE (UNII: 25BB7EKE2E)  
CITRIC ACID MONOHYDRATE (UNII: 2968PHW8QP)  
ROSA ROXBURGHII FRUIT (UNII: CVT1AA87FF)  
GOLD (UNII: 79Y1949PYO)  
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:58411-657-101 in 1 CARTON05/01/2021
140 mL in 1 TUBE; Type 0: Not a Combination Product
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC monograph not finalpart35205/01/2021
Labeler - SHISEIDO AMERICAS CORPORATION (193691821)

Revised: 3/2021
Document Id: 5372d970-e30f-48ff-b10f-2b2f74dfccc9
Set id: ff088b0c-27c9-4ea8-bf94-6261378c7190
Version: 1
Effective Time: 20210326
 
SHISEIDO AMERICAS CORPORATION